nf11_1_resistant_vs_parental_interactive.html

syn69980491

Created By Sasha Scott Sasha.scott

studyId: syn53604892
studyName: Advancing RAS pathway targeted therapy in NF1-MPNST - effects of SHP2 and CDK4 or CDK6 inhibitors on the tumor and the tumor immune microenvironment
initiative: Other
fundingAgency: Other

nf11_1_resistant_vs_parental_interactive.html page is loading…